Breaking news: the FDA has approved the use of Esketamine—a low-dose nasal ketamine spray—for the treatment of depression, PTSD, and other mood disorders! FDA approval for Esketamine came less than[...]
Ketamine Infusion Therapy: An Innovative Treatment Option for RSD / CRPS
A Ketamine-Based Nasal Spray For Depression Has Just Been Approved by The FDA The Food and Drug Administration approved a novel antidepressant late Tuesday for people with depression that does not[...]
Low Dose Ketamine Infusions for Acute and Chronic Pain Guidelines In a huge step forward, a well-respected group of physicians has issued a set of guidelines for the use of ketamine in the treatment[...]
Clinical depression is the second most common form of mental illness in the United States after anxiety disorders, and may impact as many as 16 million Americans annually. Clinical depression can be[...]
Ketamine Infusion Therapy and Anxiety Disorders Anxiety disorder is different. For individuals suffering from an anxiety disorder, feelings of anxiety and panic are more than a temporary response to[...]
Ketamine and the Lateral Habenula, the Brain’s Reward Center The medical community is increasingly excited by the ever-growing body of scientific literature exploring the unique anti-depressive[...]
Over the past several decades, scientists have made significant advances in understanding how the brain functions. Yet despite this progress, medical science has yet to develop a successful strategy[...]
LETTER FROM DR. MANDEL Have you been able to keep warm this February? Being located in sunny Southern California I know that I have no place to complain about being cold, however, I am blown away by[...]
We hear a lot in the media these days about the outrageous and sometimes prohibitive cost of prescription medication. What we don’t often hear about is the amount of time and money it takes to[...]
